Devereux, Richard B.
Weill Cornell Medicine
23 papers on CoChatORCID 0000-0002-8542-4982
Most cited papers
- Verified
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography
Cardiovascular Function and Risk FactorsCardiac Imaging and Diagnostics
Cited by 11,318
- Verified
Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet
Blood Pressure and Hypertension StudiesRenin-Angiotensin System Studies
Cited by 5,407
- Verified
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
Koren, M. J., Devereux, R. B., Casale, P. N., Savage, D. D., & Laragh, J. H. (1991) · Annals of Internal Medicine
Cardiovascular Function and Risk FactorsBlood Pressure and Hypertension Studies
Cited by 2,366
- Verified
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet
Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes
Cited by 1,560
- Verified
Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality
Min, J. K., Shaw, L. J., Devereux, R. B., Okin, P. M., Weinsaft, J. W., Russo, D. J., Lippolis, N. J., Berman, D. S., & Callister, T. Q. (2007) · Journal of the American College of Cardiology
Cardiac Imaging and DiagnosticsCoronary Interventions and Diagnostics
Cited by 1,055
- Verified
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol
Wachtell, K., Lehto, M., Gerdts, E., Olsen, M. H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen, S. E., Lindholm, L. H., et al. (2005) · Journal of the American College of Cardiology
Atrial Fibrillation Management and OutcomesBlood Pressure and Hypertension Studies
Cited by 826
- Verified · note
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
Ibsen, H., Olsen, M. H., Wachtell, K., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlöf, B., Devereux, R. B., de Faire, U., Fyhrquist, F., et al. (2005) · Hypertension
Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes
Cited by 562
- Verified
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study
Wachtell, K., Ibsen, H., Olsen, M. H., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlf, B., Devereux, R. B., Beevers, G., de Faire, U., et al. (2003) · Annals of Internal Medicine
Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies
Cited by 557
- Verified
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
Lindholm, L. H., Ibsen, H., Borch-Johnsen, K., Olsen, M. H., Wachtell, K., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., et al. (2002) · Journal of Hypertension
Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 392
- Verified
Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults.
de Simone, G., Devereux, R. B., Roman, M. J., Alderman, M. H., & Laragh, J. H. (1994) · Hypertension
Cardiovascular Function and Risk FactorsBlood Pressure and Hypertension Studies
Cited by 391
- Verified
Midwall Left Ventricular Mechanics: An Independent Predictor of Cardiovascular Risk in Arterial Hypertension
de Simone, G., Devereux, R. B., Koren, M. J., Mensah, G. A., Casale, P. N., & Laragh, J. H. (1996) · Circulation
Cardiovascular Function and Risk FactorsCardiac Imaging and Diagnostics
Cited by 374
- Verified
Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects: Hypertension Genetic Epidemiology Network (HyperGEN) Study
Palmieri, V., Bella, J. N., Arnett, D. K., Liu, J. E., Oberman, A., Schuck, M.-Y., Kitzman, D. W., Hopkins, P. N., Morgan, D., Rao, D. C., et al. (2001) · Circulation
Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 339
- Verified
Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events.
Devereux, R. B., & Alderman, M. H. (1993) · Circulation
Cardiovascular Health and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 298
- Verified
Impact of Obesity on Cardiac Geometry and Function in a Population of Adolescents
Chinali, M., de Simone, G., Roman, M. J., Lee, E. T., Best, L. G., Howard, B. V., & Devereux, R. B. (2006) · Journal of the American College of Cardiology
Cardiovascular Function and Risk FactorsObesity, Physical Activity, Diet
Cited by 248
- Verified
Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
Weber, M. A., Bakris, G. L., Jamerson, K., Weir, M., Kjeldsen, S. E., Devereux, R. B., Velazquez, E. J., Dahlöf, B., Kelly, R. Y., Hua, T. A., et al. (2010) · Journal of the American College of Cardiology
Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes
Cited by 244
- Verified
Normalization for body size and population-attributable risk of left ventricular hypertrophyThe Strong Heart Study
DESIMONE, G., KIZER, J., CHINALI, M., ROMAN, M., BELLA, J., BEST, L., LEE, E., & DEVEREUX, R. (2005) · American Journal of Hypertension
Cardiovascular Function and Risk FactorsBlood Pressure and Hypertension Studies
Cited by 233
- Verified
A Longitudinal Study of Hypertension Risk Factors and Their Relation to Cardiovascular Disease: The Strong Heart Study
Wang, W., Lee, E. T., Fabsitz, R. R., Devereux, R., Best, L., Welty, T. K., & Howard, B. V. (2006) · Hypertension
Blood Pressure and Hypertension StudiesSodium Intake and Health
Cited by 228
- Verified
Low-Flow Aortic Stenosis in Asymptomatic Patients
Cramariuc, D., Cioffi, G., Rieck, Å. E., Devereux, R. B., Staal, E. M., Ray, S., Wachtell, K., & Gerdts, E. (2009) · JACC: Cardiovascular Imaging
Cardiac Valve Diseases and TreatmentsCardiovascular Function and Risk Factors
Cited by 211
- Verified
Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors
Howard, B. V., Best, L. G., Galloway, J. M., Howard, W. J., Jones, K., Lee, E. T., Ratner, R. E., Resnick, H. E., & Devereux, R. B. (2006) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 180
- Verified
Mitral valve prolapse: causes, clinical manifestations, and management
Devereux, R. B., Kramer-Fox, R., & Kligfield, P. (1989) · Annals of Internal Medicine
Cardiac Valve Diseases and TreatmentsCardiomyopathy and Myosin Studies
Cited by 180
- Verified
Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study)**The views expressed here are those of the authors and do not necessarily reflect those of the Indian Health Service.
Chinali, M., Devereux, R. B., Howard, B. V., Roman, M. J., Bella, J. N., Liu, J. E., Resnick, H. E., Lee, E. T., Best, L. G., & de Simone, G. (2004) · The American Journal of Cardiology
Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 157
- Verified
Relation between the presence of echocardiographic vegetations and the complication rate in infective endocarditis
Lutas, E. M., Roberts, R. B., Devereux, R. B., & Prieto, L. M. (1986) · American Heart Journal
Infective Endocarditis Diagnosis and ManagementCardiac Valve Diseases and Treatments
Cited by 131
- Verified
Effect of Changing Heart Rate During Treatment of Hypertension on Incidence of Heart Failure
Okin, P. M., Kjeldsen, S. E., Julius, S., Hille, D. A., Dahlöf, B., & Devereux, R. B. (2012) · The American Journal of Cardiology
Blood Pressure and Hypertension StudiesHeart rate and cardiovascular health
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free